MTM Vision Fall 2024 Symposium | Announcement: Boehringer Ingelheim and MTM Vision Join Forces to Combat Vision Loss from Diabetes 

  • S. Robert Levine, MD । Founder and CEO, MTM Vision
  • Marianne Laouri, PhD, Global Asset Lead, Retinal Health, Boehringer Ingelheim Pharmaceuticals

Latest news

Twenty Year Trends in Prevalence and in Incidence of Diabetic Retinal Disease
Our Publications
Twenty Year Trends in Prevalence and in Incidence of Diabetic Retinal Disease

Ophthalmology Science (January 2025) ...

Read more Twenty Year Trends in Prevalence and in Incidence of Diabetic Retinal Disease
University of Michigan’s Kellogg Eye Center Annual Report
News
University of Michigan’s Kellogg Eye Center Annual Report

Read more University of Michigan’s Kellogg Eye Center Annual Report
Personal Experience | Kim Hartman
Personal Experiences
Personal Experience | Kim Hartman

Read more Personal Experience | Kim Hartman
Close newsletter

Join Our Email List

By submitting this form, you are consenting to receive marketing emails from: Mary Tyler Moore Vision Initiative. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact